COMPARATIVE EVALUATION OF OVULATION INDUCTION AGENTS IN POLYCYSTIC OVARY SYNDROME (PCOS)-RELATED INFERTILITY: A RANDOMIZED CLINICAL TRIAL
Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-aged women, affecting 5–20% depending on diagnostic criteria. PCOS is a leading cause of anovulatory infertility and presents with hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-06-07
- DOI
- https://doi.org/10.5281/zenodo.15612732
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00